MMP9 rs3918242: Understanding the Promoter Variant
The rs3918242 variant is a single-nucleotide polymorphism located in the promoter region of the MMP9 gene. It has been studied for its potential influence on enzyme activity and its statistical associations with various cardiovascular and tissue-remodeling traits.
What each genotype means
Baseline promoter activity
This is the most common genotype for this variant. Research suggests this version of the promoter may result in lower baseline expression of the MMP9 enzyme compared to the T allele, though associations with health outcomes like cardiovascular risk or skin elasticity remain inconsistent across different populations.
This is the major genotype found in the majority of individuals across most global populations.
Increased promoter activity
Carrying one copy of the T allele has been associated in some studies with higher levels of MMP9 enzyme activity. While some research links this genotype to a slightly increased statistical risk for certain cardiovascular conditions or altered skin elasticity, results are mixed and evidence remains limited.
Carried by a significant minority of individuals, with frequencies varying notably between European and East Asian populations.
Higher promoter activity
Individuals with this genotype possess two copies of the T allele, which has been linked in some studies to higher circulating levels of the MMP9 enzyme. While some research suggests a potential association with increased susceptibility to specific cardiovascular or inflammatory traits, these findings are not universal and should be interpreted with caution.
This is the least common genotype, occurring less frequently than the C/C or C/T genotypes in most studied populations.
What is the rs3918242 Variant?
The rs3918242 variant is a specific genetic change where a cytosine (C) is replaced by a thymine (T) at a position 1562 base pairs upstream from the transcription start site of the MMP9 gene. Because this location sits within the promoter region—the "on-off switch" for gene expression—researchers have long hypothesized that this change might alter how much MMP-9 protein a cell produces. Located on chromosome 20, this variant is often referred to in scientific literature as the -1562C>T polymorphism. While it is a well-documented site of variation, it is important to note that genetic variants in promoter regions do not always result in significant changes to protein levels in every individual or tissue type. The functional impact of this specific change remains a subject of ongoing investigation in molecular biology.
The Role of the MMP9 Gene
The MMP9 gene provides instructions for making an enzyme called matrix metalloproteinase-9. This enzyme belongs to a family of proteins that break down components of the extracellular matrix, which is the structural scaffolding that supports cells in the body. Specifically, MMP-9 is known for its ability to degrade type IV and V collagens, which are essential parts of basement membranes. By remodeling these structural proteins, MMP-9 plays a critical role in various physiological processes, including tissue repair, bone development, and the movement of immune cells. However, because it is so effective at breaking down structural barriers, its activity is tightly regulated. When this regulation is disrupted, or when the enzyme is overactive, it may contribute to processes like inflammation, tumor-associated tissue remodeling, or the progression of vascular disease.
Research Associations and Evidence Strength
Research into rs3918242 has primarily focused on its potential link to cardiovascular health and tissue remodeling. Some studies have suggested that the T allele may be associated with increased promoter activity and higher circulating levels of the MMP-9 enzyme. Consequently, researchers have investigated whether this variant correlates with risks for conditions such as myocardial infarction or the progression of left ventricular dysfunction, particularly in patients with diabetes. However, the evidence remains limited and sometimes conflicting. While some studies report statistical associations, others have found no significant correlation, or have noted that results vary widely across different populations. Because these associations are often based on observational studies rather than large-scale clinical trials, the evidence is not considered definitive. It is best viewed as a candidate marker for further research rather than a diagnostic tool for predicting individual health outcomes.
What You Can and Cannot Do With This Information
Understanding your genotype for rs3918242 is primarily an educational exercise in genomics. Because the evidence linking this variant to specific health outcomes is limited and inconsistent, it cannot be used to predict your personal risk for heart disease or other conditions. Genetic markers are only one small piece of a much larger puzzle that includes diet, lifestyle, environment, and other genetic factors. You should never use information about this variant to make medical decisions, such as starting or stopping medications or changing your health regimen. If you have concerns about your cardiovascular health or family history, the most effective approach is to consult with a qualified healthcare provider. They can evaluate your overall health profile, including established clinical markers, to provide guidance tailored to your specific needs.
How common is this variant?
The minor T allele of rs3918242 has a frequency of approximately 0.10 to 0.20 in European and East Asian populations, though frequencies can vary by specific ancestry.
Frequently asked questions
Is rs3918242 a diagnostic test for heart disease?
No, rs3918242 is not a diagnostic test. The scientific evidence linking this variant to heart disease is limited and inconsistent, meaning it cannot reliably predict an individual's risk.
Does having the T allele mean I have high MMP-9 levels?
Not necessarily. While some research suggests the T allele may influence promoter activity, many factors, including other genes and environmental triggers, determine the actual levels of MMP-9 in your body.
Should I change my diet based on my MMP9 genotype?
There is no scientific evidence to support changing your diet based on this specific genetic variant. Always consult with a doctor or registered dietitian before making significant changes to your nutrition.
Where can I find more information on MMP9?
You can explore resources like MedlinePlus Genetics or the GeneCards database for comprehensive, peer-reviewed information about the function and clinical relevance of the MMP9 gene.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3918242?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MMP9
Functional promoter variant (-1562C>T) in matrix metallopeptidase 9 altering promoter activity and gelatinase release.
Missense variant in MMP-9 (R279Q) altering gelatinase activity, impacting matrix degradation and structural dermal photo-aging.
Functional coding variant (R279Q) altering matrix metalloproteinase-9 activity, influencing collagen degradation and solar elastosis upon UV photo-exposure.
This SNP is associated with matrix metalloproteinase activity and cardiovascular disease risk.